Syndax Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 17
EBIT TTM (mln): -297
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 1 1 2 2 2 2 140 0 0 24
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% inf% 94.6% 72.8% -28.0% 0.0% 0.0% 9109.6% -100.0% 0.0% inf%
Marża brutto -inf% 0.0% 0.0% 0.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 99.7% -inf% -inf% 96.5%
EBIT (mln) -10 -9 -9 -21 -21 -44 -62 -76 -58 -71 26 -152 -230 -340
EBIT Δ r/r 0.0% -9.2% -1.9% 148.9% -3.8% 113.4% 41.6% 22.5% -24.2% 24.1% -136.7% -678.8% 51.5% 47.7%
EBIT (%) 0.0% 0.0% 0.0% 0.0% -3271.6% -3587.4% -2939.0% -5001.7% -3792.9% -4708.2% 18.8% 0.0% 0.0% -1434.4%
Koszty finansowe (mln) 2 0 0 0 2 1 1 2 2 2 2 3 0 5
EBITDA (mln) -11 -12 -7 -23 -20 -44 -62 -76 -58 -71 26 -152 -230 -314
EBITDA(%) 0.0% 0.0% 0.0% 0.0% -3248.5% -3587.4% -2939.0% -5001.7% -3792.9% -4708.2% 18.8% 0.0% 0.0% -1325.3%
Podatek (mln) 0 1 3 -2 2 -0 -0 2 -0 -0 -0 -6 0 0
Zysk Netto (mln) -13 -10 -14 -20 -24 -44 -61 -74 -56 -73 25 -144 -209 -319
Zysk netto Δ r/r 0.0% -23.9% 42.2% 39.9% 21.6% 84.4% 36.7% 21.6% -24.3% 30.6% -134.1% -676.7% 45.6% 52.3%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% -3846.7% -3645.2% -2884.3% -4875.5% -3688.5% -4816.7% 17.8% 0.0% 0.0% -1346.1%
EPS -21.11 -0.14 -1.77 -2.07 -1.39 -3.04 -2.9 -2.92 -1.84 -1.77 0.48 -2.37 -2.98 -3.73
EPS (rozwodnione) -21.11 -0.14 -1.77 -2.07 -1.39 -3.04 -2.9 -2.92 -1.84 -1.77 0.46 -2.37 -2.98 -3.73
Ilośc akcji (mln) 1 70 8 10 17 15 21 25 30 41 52 61 70 85
Ważona ilośc akcji (mln) 1 70 8 10 17 15 21 25 30 41 54 61 70 85
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD